Investor Relations

English Español Português Deutsch

Khiron Becomes First Company to Sell Medical Cannabis in Peru, and Surpasses 3,000 Prescriptions in Colombia

View Press Release View All

Sep 22, 2020 • 8:47 AM EDT

Khiron Declared a National Strategic Project by the Government of Colombia

Sep 11, 2020 • 4:24 PM EDT

Khiron Announces Shareholder Approval of Amended and Restated Option Plan and Restricted Share Unit Plan, and Grants of RSUs

Sep 4, 2020 • 8:30 AM EDT

/R E P E A T -- Khiron Enters Exclusive Partnership with RAPPI, Latin America's Largest Home Multi-Vertical App Platform/

View Presentation

Upcoming Event

Sep 30, 2020 • 9:30 am EDT

Cannacord: 2020 Virtual US Cannabis Symposium

View Event Add to Calendar

View All

Q2 2020

Quarter Ended Jun 30, 2020

Earnings Release

PDF HTML

Audio

Earnings Webcast

Financial Statements

PDF

MD&A

PDF

Company Overview

Khiron Life Sciences (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC) is a vertically integrated global medical and CPG cannabis leader with core operations in Latin America and Europe. We currently have distribution throughout various countries in Latin America, along with activity in North America and Europe. The company is licensed in Colombia for the cultivation, production, domestic distribution, and international export of both low and high THC medical cannabis products from Colombia to UK, Peru and Uruguay/Brazil.

View Management Team View Board of Directors

Investor Contact Information

Company

Khiron Life Sciences Corp.
100 King Street West
Suite 1600
Toronto, Ontario M5X 1A9
Canada